The DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.
ROCplot.org: Validating predictive biomarkers of chemotherapy/hormonal therapy/anti‐HER2 therapy using transcriptomic data of 3,104 breast cancer patients
Open accessAbstract
Systemic therapy of breast cancer can include chemotherapy, hormonal therapy and targeted therapy. Prognostic biomarkers are able to predict survival and predictive biomarkers are able to predict therapy response. In this report, we describe the initial release of the first available online tool able to identify gene expression‐based predictive biomarkers using transcriptomic data of a large set of breast cancer patients. Published gene expression data of 36 publicly available datasets were integrated with treatment data into a unified database. Response to therapy was determined using either author‐reported pathological complete response data (n = 1,775) or relapse‐free survival status at 5 years (n = 1,329). Treatment data includes chemotherapy (n = 2,108), endocrine therapy (n = 971) and anti‐human epidermal growth factor receptor 2 (HER2) therapy (n = 267). The transcriptomic database includes 20,089 unique genes and 54,675 probe sets. Gene expression and therapy response are compared using receiver operating characteristics and Mann–Whitney tests. We demonstrate the utility of the pipeline by cross‐validating 23 paclitaxel resistance‐associated genes in different molecular subtypes of breast cancer. An additional set of established biomarkers including TP53 for chemotherapy in Luminal breast cancer (p = 1.01E‐19, AUC = 0.769), HER2 for trastuzumab therapy (p = 8.4E‐04, AUC = 0.629) and PGR for hormonal therapy (p = 8.6E‐05, AUC = 0.7), are also endorsed. The tool is designed to validate and rank new predictive biomarker candidates in real time. By analyzing the selected genes in a large set of independent patients, one can select the most robust candidates and quickly eliminate those that are most likely to fail in a clinical setting. The analysis tool is accessible at www.rocplot.org.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Multidrug resistance in cancer: role of ATP–dependent transporters
Gottesman, M. M., Fojo, T., & Bates, S. E. (2002) · Nature Reviews Cancer · doi:10.1038/nrc706 · Cited by 5,536
Hammond, M. E. H., Hayes, D. F., Dowsett, M., Allred, D. C., Hagerty, K. L., Badve, S., Fitzgibbons, P. L., Francis, G., Goldstein, N. S., Hayes, M., et al. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.25.6529 · Cited by 4,213
Györffy, B., Lanczky, A., Eklund, A. C., Denkert, C., Budczies, J., Li, Q., & Szallasi, Z. (2010) · Breast Cancer Research and Treatment · doi:10.1007/s10549-009-0674-9 · Cited by 4,169
Self-citationTopoisomerase I inhibitors: camptothecins and beyond
Pommier, Y. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1977 · Cited by 2,277
Systemic treatment of early breast cancer by hormonal, cytotoxic, or immune therapy
Early Breast Cancer Trialist's Collaborative Group (1992) · The Lancet · doi:10.1016/0140-6736(92)90997-h · Cited by 2,182
Kastner, P., Krust, A., Turcotte, B., Stropp, U., Tora, L., Gronemeyer, H., & Chambon, P. (1990) · The EMBO Journal · doi:10.1002/j.1460-2075.1990.tb08280.x · Cited by 1,534
Curigliano, G., Burstein, H. J., Winer, E. P., Gnant, M., Dubsky, P., Loibl, S., Colleoni, M., Regan, M. M., Piccart-Gebhart, M., Senn, H.-J., et al. (2017) · Annals of Oncology · doi:10.1093/annonc/mdx308 · Cited by 1,205
Dunnwald, L. K., Rossing, M. A., & Li, C. I. (2007) · Breast Cancer Research · doi:10.1186/bcr1639 · Cited by 785
Lánczky, A., Nagy, Á., Bottai, G., Munkácsy, G., Szabó, A., Santarpia, L., & Győrffy, B. (2016) · Breast Cancer Research and Treatment · doi:10.1007/s10549-016-4013-7 · Cited by 768
Self-citationPlatinum Resistance: The Role of DNA Repair Pathways
Martin, L. P., Hamilton, T. C., & Schilder, R. J. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-2238 · Cited by 751
Taxanes, microtubules and chemoresistant breast cancer
McGrogan, B. T., Gilmartin, B., Carney, D. N., & McCann, A. (2008) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2007.10.004 · Cited by 535
Dihydropyrimidine dehydrogenase and the efficacy and toxicity of 5-fluorouracil
van Kuilenburg, A. B. P. (2004) · European Journal of Cancer · doi:10.1016/j.ejca.2003.12.004 · Cited by 488
Jetset: selecting the optimal microarray probe set to represent a gene
Li, Q., Birkbak, N. J., Gyorffy, B., Szallasi, Z., & Eklund, A. C. (2011) · BMC Bioinformatics · doi:10.1186/1471-2105-12-474 · Cited by 324
Trastuzumab in the Treatment of Breast Cancer
Hortobagyi, G. N. (2005) · New England Journal of Medicine · doi:10.1056/nejme058196 · Cited by 306
bc-GenExMiner 3.0: new mining module computes breast cancer gene expression correlation analyses
Jezequel, P., Frenel, J.-S., Campion, L., Guerin-Charbonnel, C., Gouraud, W., Ricolleau, G., & Campone, M. (2013) · Database · doi:10.1093/database/bas060 · Cited by 258
Multigene prognostic tests in breast cancer: past, present, future
Győrffy, B., Hatzis, C., Sanft, T., Hofstatter, E., Aktas, B., & Pusztai, L. (2015) · Breast Cancer Research · doi:10.1186/s13058-015-0514-2 · Cited by 257
Self-citationKhleif, S. N., Doroshow, J. H., & Hait, W. N. (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-0880 · Cited by 186
Taxol resistance mediated by transfection of the liver-specific sister gene of P-glycoprotein.
Childs, S. J., Yeh, R. L., Hui, D., & Ling, V. W. T. (1998) · PubMed · Cited by 141
PROGgene: gene expression based survival analysis web application for multiple cancers
Goswami, C. P., & Nakshatri, H. (2013) · Journal of Clinical Bioinformatics · doi:10.1186/2043-9113-3-22 · Cited by 141
Madden, S. F., Clarke, C., Gaule, P., Aherne, S. T., O’Donovan, N., CLYNES, M. M., Crown, J. P., & Gallagher, W. M. (2013) · Breast Cancer Research · doi:10.1186/bcr3444 · Cited by 137
Overexpression of OATP1B3 Confers Apoptotic Resistance in Colon Cancer
Lee, W., Belkhiri, A., Lockhart, A. C., Merchant, N. B., Glaeser, H., Harris, E. I., Washington, M. K., Brunt, E. M., Zaika, A., Kim, R. B., et al. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-1984 · Cited by 134
Nami, B., & Wang, Z. (2018) · Cancers · doi:10.3390/cancers10080274 · Cited by 124
Dorman, S., Baranova, K., Knoll, J. H. M., Urquhart, B. L., Mariani, G., Carcangiu, M. L., & Rogan, P. K. (2015) · Molecular Oncology · doi:10.1016/j.molonc.2015.07.006 · Cited by 119
Abdul‐Ghani, R., Serra, V., Győrffy, B., Jürchott, K., Solf, A., Dietel, M., & Schäfer, R. (2005) · Oncogene · doi:10.1038/sj.onc.1209201 · Cited by 115
Self-citationHarmsen, S., Meijerman, I., Beijnen, J. H., & Schellens, J. H. M. (2008) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-008-0842-3 · Cited by 102
Győrffy, B., Benke, Z., Lánczky, A., Balázs, B., Szállási, Z., Tı́már, J., & Schäfer, R. (2011) · Breast Cancer Research and Treatment · doi:10.1007/s10549-011-1676-y · Cited by 98
Self-citationBanerjee, A. K. (2002) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(02)00269-3 · Cited by 94
Kütük, Ö., & Letai, A. G. (2010) · Cell Death and Differentiation · doi:10.1038/cdd.2010.41 · Cited by 91
Yarnold, J. R. (2009) · Clinical Oncology · doi:10.1016/j.clon.2008.12.008 · Cited by 78
Antonov, A. V., Krestyaninova, M., Knight, R. A., Rodchenkov, I. V., Melino, G., & Barlev, N. A. (2013) · Oncogene · doi:10.1038/onc.2013.119 · Cited by 59
Flores, M. L., Castilla, C., Ávila, R., Ruíz‐Borrego, M., Sáez, C., & Japón, M. Á. (2011) · Breast Cancer Research and Treatment · doi:10.1007/s10549-011-1864-9 · Cited by 48
Durán, G. E., Wang, Y. C., Moisan, F., Francisco, E. B., & Sikic, B. I. (2017) · British Journal of Cancer · doi:10.1038/bjc.2017.102 · Cited by 48
García‐Martín, E., Pizarro, R. M., Martı́nez, C., Gutiérrez-Martı́n, Y., Pérez, G., Jover, R., & Agúndez, J. A. G. (2006) · Pharmacogenomics · doi:10.2217/14622416.7.4.575 · Cited by 44
Chen, X., Miao, Z., Divate, M. D., Zhao, Z., & Cheung, E. C. W. (2018) · Database · doi:10.1093/database/bay069 · Cited by 26
Cited by
Bartha, Á., & Győrffy, B. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22052622 · Cited by 1,060
Self-citation
Metadata
- Authors
- Fekete, J. T., & Győrffy, B.
- Venue
- International Journal of Cancer
- Publisher
- Wiley
- Published
- 2019-05-07
- Volume
- 145
- Issue
- 11
- Pages
- 3140-3151
- ISSN
- 0020-7136 (ISSN-L)
- 1097-0215
- OpenAlex
- W2941467331
- Cited by
- 422
- References
- 34
- FWCI
- 8.78
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.